Ss. Jonnalagadda et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF 1,1-DICHLORO-2,3-DIARYLCYCLOPROPANES AS ANTITUBULIN AND ANTI-BREAST CANCER AGENTS, Bioorganic & medicinal chemistry, 5(4), 1997, pp. 715-722
Z-1,1-Dichloro-2,3-diphenylcyclopropane (1) is an effective 'anti-brea
st cancer agent in rodents and in cell culture. We recently determined
that 1 inhibits tubulin assembly in vitro. and causes microtubule los
s in breast cancer cells, leading to accumulation in the G2/M portion
of the cell cycle. Aryl ring-halogenated, methoxylated and benzyloxyla
ted derivatives of 1, as well as its E-isomer and the dichlorocyclopro
pyl derivative of diethylstilbestrol (DES), were synthesized and teste
d for their ability to inhibit the assembly of tubulin into micro tubu
les. Including 1, 17 cyclopropyl compounds were tested. One -dichloro-
2-(4-methoxyphenyl)-3-phenylcyclopropane (12)) was found to be more ac
tive than 1. In addition, E-1,1-dichlorocyclopropylDES (17) was more p
otent than DES. The E-isomer of 1 (16) was inactive. The cytostatic ac
tivities of the compounds against MCF-7 and MDA-MB231 human breast can
cer cells, and their abilities to perturb microtubules in MCF-7 cells
were also evaluated. Z-Dichloro-2-(4-fluorophenyl)-3-phenylcyclo (5),
2-(4-fluorophenyl)-3-(4-methoxyphenyl)cyclopropane (11), and Z-1,1-dic
hloro-2-(4-methoxyphenyl) -3-phenylcyclopropane (12) were more potent
than 1 against the breast cancer cells. (C) 1997 Elsevier Science Ltd.